Form 4 for DBD DIEBOLD NIXDORF, Inc
Accepted 2025-03-03 00:00:00 ET · period of report 2025-03-01 · accession 0000028823-25-000039 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-03 | 2025-03-01 | DBD | Marquez Octavio | Pres, CEO, Dir | A - Grant | $0.00 | +69.5K | 203.8K | +52% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-01 | A | A | 69,523 | $0.00 | 203,811 | D | — | — | (F1) Award of Restricted Stock Units granted under the Diebold Nixdorf, Incorporated 2023 Equity and Incentive Plan, as amended, and vesting in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant; each Restricted Stock Unit represents a contingent right to receive one share of Diebold Nixdorf, Incorporated common stock. (F2) Number includes Restricted Stock Units. |